Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $753.02 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $117.26 | 1 | $0 (2018) |
| PFIZER INC. | $110.70 | 1 | $0 (2017) |
| Amgen Inc. | $101.95 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $95.00 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $93.26 | 1 | $0 (2018) |
| Incyte Corporation | $92.91 | 1 | $0 (2019) |
| Amarin Pharma Inc. | $76.33 | 1 | $0 (2023) |
| Novo Nordisk Inc | $65.61 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $76.33 | 1 | Amarin Pharma Inc. ($76.33) |
| 2022 | $65.61 | 1 | Novo Nordisk Inc ($65.61) |
| 2019 | $187.91 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($95.00) |
| 2018 | $312.47 | 3 | Abbott Laboratories ($117.26) |
| 2017 | $110.70 | 1 | PFIZER INC. ($110.70) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $76.33 | General |
| Category: Cardiovascular | ||||||
| 05/05/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $65.61 | General |
| Category: Diabetes | ||||||
| 11/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: DIABETES | ||||||
| 02/04/2019 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $92.91 | General |
| 10/01/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $93.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2018 | Abbott Laboratories | HeartMate (Device) | Food and Beverage | In-kind items and services | $117.26 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/07/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $101.95 | General |
| Category: Cardiology | ||||||
| 04/03/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $110.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
About Dr. Gary Rahe, M.D
Dr. Gary Rahe, M.D is a Hematology & Oncology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154378388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Rahe, M.D has received a total of $753.02 in payments from pharmaceutical and medical device companies, with $76.33 received in 2023. These payments were reported across 8 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($753.02).
Practice Information
- Specialty Hematology & Oncology
- Location Oklahoma City, OK
- Active Since 05/31/2006
- Last Updated 10/22/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1154378388
Products in Payments
- HeartMate (Device) $117.26
- ELIQUIS (Drug) $110.70
- Repatha (Biological) $101.95
- JARDIANCE (Drug) $95.00
- XIFAXAN (Drug) $93.26
- Vascepa (Drug) $76.33
- Ozempic (Drug) $65.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Oklahoma City
Robert Reynolds, Md, MD
Hematology & Oncology — Payments: $14,579
Philip Comp, Md, MD
Hematology & Oncology — Payments: $13,151
Dr. Charles Hollen, M.d, M.D
Hematology & Oncology — Payments: $12,135
Jennifer Holter-Chakrabarty, Md, MD
Hematology & Oncology — Payments: $11,994
Dr. Saadia Chohan, Md, MD
Hematology & Oncology — Payments: $11,197
Abby Bova, Md, MD
Hematology & Oncology — Payments: $5,791